Meanwhile, on the research front, a computational model of autism (Béroule, 2018) predicted that besides its classical anticonvulsant properties, VPA could serve as an autism-modifying drug for its capacity to promote the type A monoamine oxidase (MAOA) genetic expression (Gupta et al., 2015). The gene discussed is MAOA; the disease is autism.